Results 111 to 120 of about 10,117 (217)

Placing purines in precision medicine: Targeting a metabolic reliance in <i>KRAS</i>-mutant tumors. [PDF]

open access: yesiScience
De Boni L   +9 more
europepmc   +1 more source

Targeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine Response. [PDF]

open access: yesNat Commun
Marques AMC   +13 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. [PDF]

open access: yesClin Pharmacol Ther
Maillard M   +18 more
europepmc   +1 more source

The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel disease. [PDF]

open access: yesBr J Clin Pharmacol
Bouwknegt DG   +13 more
europepmc   +1 more source

A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden. [PDF]

open access: yesCancer Res Commun
Secher CF   +10 more
europepmc   +1 more source

Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report. [PDF]

open access: yesClin Transl Sci
Fry J   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy